Nov 6

TOBI Faculty Andrew Ittleman on the FDA’s Regulation of Stem Cells

TOBI 2017 Faculty Andrew Ittleman, JD, has published a valuable article on how the FDA should regulate human cells. This article, which appeared in The Regulatory Review, provides a brief history of the FDA's involvement in the regulation of human cells, starting with the Wall Street Journal Op-ed, "The FDA Wants to Regulate Your Cells", written by Scott Gottlieb in 2012. Gottlieb is now the Commissioner of the FDA. Ittleman analyzes Gottlieb's political history regarding the regulation of human cells,...

May 23

TOBI Faculty Publications: April 2017

Below is a resource of all April 2017 regenerative medicine publications authored by TOBI Speakers and Faculty, including alumni faculty. Each month, we compile a list with links and brief summaries of all new research and studies to keep TOBI community members informed and on the cutting edge of regenerative medicine research. Studies are listed alphabetically by TOBI Faculty names. If you are a TOBI Faculty member or alumni and would like your publications included in the TOBI monthly publications...

Feb 9

January 2017: TOBI Faculty Publications in Regenerative Medicine

TOBI Faculty Publications: January 2017 January 2017, Stem Cells and Development Autologous and Allogeneic Equine Mesenchymal Stem Cells Exhibit Equivalent Immunomodulatory Properties In Vitro. TOBI Faculty C. Wayne McIlwraith, MD, published this study evaluating different methods of modulating inflammatory processes related to acute or chronic musculoskeletal injuries in the horse. They conducted studies to assess the immunological properties of equine allogeneic BMDMSCs compared with those of autologous BMDMSCs. For assessment of inherent immunogenicity, the relative ability of allogeneic and autologous...